Dashboard
Manage Tickers

PLX Protalix BioTherapeutics, Inc.

NYSE protalix.com


$ 1.72 $ 0.00 (0.29 %)    

Friday, 21-Nov-2025 15:33:28 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 591.98 $ 4.65 (0.79 %)
DIA $ 462.68 $ 3.20 (0.7 %)
SPY $ 660.00 $ 4.99 (0.76 %)
TLT $ 89.44 $ -0.22 (-0.25 %)
GLD $ 373.83 $ -0.16 (-0.04 %)
$ 1.74
$ 1.74
$ 1.71 x 1,376
$ 1.73 x 2,407
$ 1.71 - $ 1.79
$ 1.32 - $ 3.10
605,353
na
139.93M
$ 0.82
$ 25.94
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-17-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-14-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-30-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 06-01-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-06-2019 03-31-2019 10-Q
28 03-18-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-06-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-16-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-08-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-protalix-biotherapeutics-lowers-price-target-to-12
HC Wainwright & Co. Maintains Buy on Prota...
11/21/2025 11:21:33

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and lowers the p...

protalix-biotherapeutics-q3-eps-003-misses-006-estimate-sales-17673m-miss-17866m-estimate
Protalix BioTherapeutics Q3 EPS $0.03 Miss...
11/13/2025 11:51:16

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate ...

earnings-scheduled-for-november-13-2025
Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

preview-protalix-biotherapeuticss-earnings
Preview: Protalix BioTherapeutics's Earnings
11/12/2025 17:02:12

protalix-biotherapeutics-unit-requests-reexamination-of-negative-opinion-issued-by-chmp-related-to-proposed-dosing-regimen-of-2-mgkg-body-weight-infused-every-4-weeks-for-elfabrio
Protalix BioTherapeutics Unit Requests Ree...
11/03/2025 21:33:09

Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have...

why-is-protalix-biotherapeutics-stock-falling-on-friday
Why Is Protalix BioTherapeutics Stock Fall...
10/17/2025 15:23:15

EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

protalix-biotherapeutics-says-chmp-denies-approval-for-every-4-week-elfabrio-regimen-in-eu-maintains-2-week-dosing-status-quo
Protalix BioTherapeutics Says CHMP Denies ...
10/17/2025 11:03:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 21:06:15

protalix-biotherapeutics-q2-sales-15658m-beat-13546m-estimate
Protalix BioTherapeutics Q2 Sales $15.658M...
08/14/2025 10:51:53

Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $1...

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

preview-protalix-biotherapeuticss-earnings
Preview: Protalix BioTherapeutics's Earnings
08/13/2025 17:02:31

protalix-biotherapeutics-appoints-gilad-mamlok-as-svp-and-cfo-effective-august-24-2025-succeeding-eyal-rubin
Protalix BioTherapeutics Appoints Gilad Ma...
07/21/2025 10:51:50

protalix-biotherapeutics-added-to-russell-3000-and-russell-2000-indexes-effective-june-27-2025-as-part-of-2025-russell-indexes-annual-reconstitution
Protalix BioTherapeutics Added To Russell ...
06/30/2025 10:52:45

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/09/2025 12:10:06

protalix-biotherapeutics-q1-eps-005-misses-003-estimate-sales-1011m-miss-2160m-estimate
Protalix BioTherapeutics Q1 EPS $(0.05) Mi...
05/09/2025 10:53:23

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

uncovering-potential-protalix-biotherapeuticss-earnings-preview
Uncovering Potential: Protalix BioTherapeu...
05/08/2025 18:02:54

protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond
Protalix BioTherapeutics Says With Debt Fu...
03/17/2025 15:56:28

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start ...

protalix-biotherapeutics-fy-2024-gaap-eps-004-beats-001-estimate-sales-5340m-miss-5394m-estimate
Protalix BioTherapeutics FY 2024 GAAP EPS ...
03/17/2025 11:00:39

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION